SeqOne

SeqOne is a clinical genomics company founded in 2017. It provides an AI-powered next-generation sequencing (NGS) platform and accompanying expert services designed to help molecular laboratories convert genomic data into clinical answers, with particular focus on variant interpretation and clinical reporting. The company positions its work within the broader push towards personalised medicine, and it serves both public and private laboratories.

The SeqOne AI-powered NGS platform supports variant interpretation and reporting for molecular laboratories, and is used by labs and national genomic programs in over 35 countries. The platform is IVDR certified. Alongside the software, SeqOne offers expert services that assist laboratories with genomic analysis, variant interpretation and clinical reporting.

Areas of application include rare and inherited diseases, oncology, preventive genomics, infectious diseases, molecular diagnostics and public health national genomic programmes. The company states a mission of making personalised medicine available to every patient and describes itself as fast-growing.